EMA releases joint strategy for regulatory agencies to 2025
The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have published their joint strategy for the next five … read more »
EMA organises public meeting on COVID-19 vaccines
The European Medicines Agency (EMA) has organised a public meeting on 11 December 2020 to inform European citizens about the … read more »
EMA releases guidance for COVID-19 vaccine approval
The European Medicines Agency (EMA) has released guidance for developers of vaccines against COVID-19 on the clinical evidence that must … read more »
EMA begins second rolling review of a COVID-19 vaccine
The European Medicines Agency (EMA) has begun a ‘rolling review’ of data on a vaccine for COVID-19, which is being … read more »
EMA reaffirms commitment to independence and transparency for COVID-19 treatments and medicines
The European Medicines Agency (EMA) has explained, in an open letter that it will consider products for the current pandemic … read more »
Analysis proves EU safety system robust
The European Medicines Agency (EMA) has produced a report into its incident management plan (EU-IMP) showing it has functioned effectively … read more »
EMA and HMA launch consultation on joint network strategy
The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have launched a consultation into their joint network strategy … read more »
EMA removes scientific advice fees for some academic work
The European Medicines Agency (EMA) will work to encourage development of medicines for rare diseases by waiving the fees it … read more »
EMA launches 2019 annual report
The annual report of the European Medicines Agency (EMA) for 2019 has been released, giving insights into the work done … read more »
Analysis of EMA Q&A for medicinal products during the COVID-19 pandemic
MAP has been provided with an analysis of the EMA COVID-19 Q&A reported on recently. The European Commission recently published … read more »
